Taking Wegovy Every Other Week: the Decision You Need to Think Through

What actually changes when you inject every other week instead of every week

Semaglutide has a half-life of roughly seven days, which is precisely why once-weekly dosing was chosen. Each injection is timed so that your plasma concentration stays within a therapeutic window by the time the next dose arrives. Stretch that to fourteen days and the drug level drops well below that window in the second week. The appetite-regulation effect that makes Wegovy work (slower gastric emptying, reduced hunger signals via GLP-1 receptors) fades before the next injection lands. You might notice hunger returning more sharply, meals feeling less controlled, or progress stalling.

Clinical trial data from STEP 1, published in the New England Journal of Medicine, established the roughly 15% average weight reduction over 68 weeks at once-weekly 2.4mg. Those results were built on consistent weekly dosing. If you are weighing up whether doing Wegovy every other week is a viable approach, it is worth knowing that no comparable evidence exists for that schedule, so there is no reliable way to predict what you would actually achieve, or whether it remains clinically worthwhile continuing at all at that interval.

None of this means a missed week is catastrophic. It means that a fortnightly pattern, if it becomes deliberate, shifts you away from an evidence-based plan onto one with no supporting data. That distinction matters when you are taking a prescription medicine with a structured titration behind it.

The specific situations where people consider a longer gap, and whether they hold up

Most people exploring this question fall into one of three situations. The first is supply. If your pharmacy cannot fulfil a dose on time, holding for a week and injecting when it arrives is different from a permanent schedule change. Your prescriber can advise whether to restart at a lower dose if the gap has been significant, and the NHS semaglutide guidance covers missed-dose steps clearly.

The second is side effects. Some people find the GI impact of Wegovy disruptive enough to wonder whether spacing doses out might soften it. This feels logical but is not well evidenced. The titration schedule (starting at 0.25mg and stepping up slowly) exists precisely to manage tolerability. If nausea or vomiting is the issue, the right conversation is with your prescriber about whether slowing the titration or staying at your current dose for longer is appropriate, rather than halving your dose frequency unilaterally.

The third is cost. If you are on a private prescription and the expense of weekly injections is a strain, that is a legitimate pressure. It is worth reading about what factors shape the cost of Wegovy in the UK and what is included in a transparent private prescription, because a structured plan you can sustain weekly is likely to deliver more clinical benefit than a cheaper fortnightly one that is not what the medicine was designed for.

There is a fourth, less common situation: a prescriber-led decision to slow the frequency temporarily in specific circumstances. That is a clinical call, made with full knowledge of your history. It is not the same as self-adjusting.

How this sits within the wider Wegovy licensed schedule

The licensed Wegovy titration in the UK runs from 0.25mg up through 0.5mg, 1.0mg, 1.7mg to 2.4mg, with roughly four weeks at each step guided by your prescriber. The Wegovy overview covers the full picture of how the treatment is structured. The 7.2mg dose (approved by the MHRA in April 2026) continues this pattern of weekly dosing at a higher maintenance level. At no point does the licensed schedule include fortnightly injections as an intended phase.

People sometimes ask about daily or more frequent dosing for the same pharmacological reason in reverse: could more frequent smaller doses reduce side effects? The answer, again, is that the licensed schedule exists because it works and has the safety data behind it. The question of injecting every five days comes up for similar reasons and gets a similar answer. Altering the interval (in either direction) moves you outside the evidence base.

If weekly injections are genuinely difficult to maintain (whether because of travel, irregular work patterns or cost) it is worth having that conversation openly with your prescriber. Our guidance on taking Wegovy every two weeks explains in more detail why that interval creates practical and clinical complications worth understanding before making any changes. That kind of consistency, built into an ordinary week, is what the clinical evidence actually supports.

What to do if you have already missed a dose or stretched the gap

If you missed last week's injection and it has now been eight or nine days, inject as soon as you remember, provided your next scheduled dose is still at least two days away. If the gap has been two weeks or more, contact your prescriber before reinjecting, as they may want you to restart at a lower dose to reduce GI side effects from what would effectively be a re-exposure. Self-managing a restart carries more risk than a brief check-in.

This is a question our prescribers hear regularly, and the answer is almost always the same: the sooner you loop someone in, the simpler the fix. If you are considering Wegovy or want to review a schedule that is not working for you, speaking to our prescribers is the place to start. Consultations are free, reviewed by a GPhC-registered Independent Prescriber, and there is no obligation to proceed. You can also explore how semaglutide works and what it is used for if you want more background before that conversation.